Cited by 1,690Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerChromatin Remodeling and Cancer

The DOI matches its Crossref record; 115 of the 122 references it cites were found in a registry or an index.

The RB and p53 pathways in cancer

Open access

Sherr, Charles J, McCormick, Frank·2002·Cancer Cell

Open this paper in CoChat — free account Open PDF

Abstract

The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(02)00102-2

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Self-citation
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citation
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“By inducing Arf and Ink4a in primary rodent fibroblasts, oncogenic Ras expression leads to growth arrest and premature senescence (Serrano et al., 1997; Ferbeyre et al., 2002).”
Background
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Untitled work
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585

Show all 122 references

Sorted by citations

Items 501–600 of 1,000

Therapeutic Targeting of DNA Replication Stress in Cancer
Gu, L., Hickey, R. J., & Malkas, L. H. (2023) · Genes · doi:10.3390/genes14071346 · Cited by 52
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression
Zhou, Y., Nakajima, R., Shirasawa, M., Fikriyanti, M., Zhao, L., Iwanaga, R., Bradford, A. P., Kurayoshi, K., Araki, K., & Ohtani, K. (2023) · Biology · doi:10.3390/biology12121511 · Cited by 52
Molecular genetics of ependymoma
Yao, Y., Mack, S. C., & Taylor, M. D. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10129 · Cited by 46
A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
Rojas, J. J., Cascalló, M., Guedan, S., Gros, A., Martínez‐Quintanilla, J., Hemminki, A., & Alemany, R. (2009) · Gene Therapy · doi:10.1038/gt.2009.103 · Cited by 46
Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells
Baldwin, A. E., Li, W., Grace, M. R., Pearlberg, J., Harlow, E., Münger, K., & Grueneberg, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806195105 · Cited by 46
p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb–Hdm2 interaction and apoptosis
Delston, R. B., Matatall, K. A., Sun, Y., Onken, M. D., & Harbour, J. W. (2010) · Oncogene · doi:10.1038/onc.2010.442 · Cited by 49
A Shared Role for RBF1 and dCAP-D3 in the Regulation of Transcription with Consequences for Innate Immunity
Longworth, M. S., Walker, J. A., Anderssen, E., Moon, N.-S., Gladden, A. B., Heck, M. M. S., Ramaswamy, S., & Dyson, N. J. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002618 · Cited by 43
Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells
Kim, S., Min, H., Lee, E. J., Kim, Y. S., Bae, K., Kang, S. S., & Lee, S. K. (2009) · Phytotherapy Research · doi:10.1002/ptr.2907 · Cited by 46
MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Barone, G., Tweddle, D. A., Shohet, J. M., Chesler, L., Moreno, L., Pearson, A. D. J., & Maerken, T. V. (2014) · Current Drug Targets · doi:10.2174/13894501113149990194 · Cited by 45
Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines
Bunt, J., de Haas, T. G., Hasselt, N. E., Zwijnenburg, D. A., Köster, J., Versteeg, R., & Kool, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0546 · Cited by 48
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma
D’Oto, A., Fang, J., Jin, H., Xu, B., Singh, S. V., Mullasseril, A., Jones, V. M., Abu‐Zaid, A., von Buttlar, X., Cooke, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27502-2 · Cited by 45
Phosphorylation of the Retinoblastoma protein (Rb) on serine-807 is required for association with Bax
Antonucci, L., Egger, J. V., & Krucher, N. A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.964093 · Cited by 45
Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo
Huber, C. G., Bobek, N., Kuball, J. H. E., Thaler, S., Hoffarth, S., Huber, C. G., Theobald, M., & Schüler, M. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401563 · Cited by 43
Characterization of the p53 Response to Oncogene-Induced Senescence
Ruiz, L., Traskine, M., Ferrer, I., Castro, E., Martínez-Leal, J. F., Kaufman, M., & Carnero, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003230 · Cited by 44
Baicalein potently suppresses angiogenesis induced by vascular endothelial growth factor through the p53/Rb signaling pathway leading to G1/S cell cycle arrest
Ling, Y., Chen, Y., Chen, P., Hui, H., Song, X., Lu, Z., Li, C., Lu, N., & Guo, Q. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010395 · Cited by 45
Post‐translational control of transcription factors: methylation ranks highly
Carr, S. M., Roworth, A. P., Chan, C. S. C., & Thangue, N. B. L. (2015) · FEBS Journal · doi:10.1111/febs.13524 · Cited by 47
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Vera, B., Martínez-Vélez, N., Xipell, E., de la Rocha, A. A., Patiño‐García, A., Castresana, J. S., González-Huarriz, M., Cascalló, M., Alemany, R., & Alonso, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147211 · Cited by 45
Mouse models for radiation-induced cancers
Rivina, L., Davoren, M. J., & Schiestl, R. H. (2016) · Mutagenesis · doi:10.1093/mutage/gew019 · Cited by 45
Neural G0: a quiescent‐like state found in neuroepithelial‐derived cells and glioma
O’Connor, S. A., Feldman, H. M., Arora, S., Hoellerbauer, P., Toledo, C. M., Corrin, P. D., Carter, L. M., Kufeld, M., Bolouri, H., Basom, R., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209522 · Cited by 48
A Proteome-Wide CDK/CRK-Specific Kinase Inhibitor Promotes Tumor Cell Death in the Absence of Cell Cycle Progression
Caligiuri, M., Becker, F., Murthi, K. K., Kaplan, F., Dédier, S., Kaufmann, C. M., Machl, A., Zybarth, G., Richard, J., Bockovich, N., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.008 · Cited by 45
Inherited Cancer Syndromes in Children and Young Adults
D'Orazio, J. A. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181ced34c · Cited by 45
The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein
Cecchini, M. J., & Dick, F. A. (2011) · Biochemical Journal · doi:10.1042/bj20101210 · Cited by 44
Antitumor Effects of a Sirtuin Inhibitor, Tenovin-6, against Gastric Cancer Cells via Death Receptor 5 Up-Regulation
Hirai, S., Endo, S., Saito, R., Hirose, M., Ueno, T., Suzuki, H., Yamato, K., Abei, M., & Hyodo, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102831 · Cited by 43
Malignant Catarrhal Fever of Cattle Is Associated with Low Abundance of IL-2 Transcript and a Predominantly Latent Profile of Ovine Herpesvirus 2 Gene Expression
Meier-Trummer, C. S., Rehrauer, H., Franchini, M., Patrignani, A., Wagner, U., & Ackermann, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006265 · Cited by 44
Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma
Hutter, G., Scheubner, M., Zimmermann, Y., Kalla, J., Katzenberger, T., Hübler, K., Roth, S., Hiddemann, W., Ott, G., & Dreyling, M. H. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20277 · Cited by 44
Oncogenic Signaling Induced by HCV Infection
Virzì, A., Suarez, A. A. R., Baumert, T. F., & Lupberger, J. (2018) · Viruses · doi:10.3390/v10100538 · Cited by 47
Protein phosphatase 1 in tumorigenesis: is it worth a closer look?
Felgueiras, J., Jerónimo, C., & Fardilha, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188433 · Cited by 47
Computational and Artificial Intelligence Techniques for Drug Discovery and Administration
Balasubramanian, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00015-3 · Cited by 44
A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy
Hu, J., Xia, X., Cheng, A., Wang, G., Luo, X., Reed, M. F., Fojo, T., Oetting, A. A., Gong, J., & Yen, P. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0499 · Cited by 44
Association between p53 and Human Papillomavirus in Head and Neck Cancer Survival
Smith, E., Wang, D., Rubenstein, L. M., Morris, W. A., Turek, L. P., & Haugen, T. H. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2597 · Cited by 44
Regulation of RB Transcription In Vivo by RB Family Members
Burkhart, D. L., Ngai, L. K., Roake, C. M., Viatour, P., Thangavel, C., Ho, V. M., Knudsen, E. S., & Sage, J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00952-09 · Cited by 45
RB Reversibly Inhibits DNA Replication via Two Temporally Distinct Mechanisms
Angus, S. P., Mayhew, C. N., Solomon, D. A., Braden, W. A., Markey, M. P., Okuno, Y., Cardoso, M. C., Gilbert, D. M., & Knudsen, E. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5404-5420.2004 · Cited by 44
Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1
Gunawardena, R. W., Siddiqui, H., Solomon, D. A., Mayhew, C. N., Held, J. D., Angus, S. P., & Knudsen, E. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400395200 · Cited by 45
Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas
Sandhu, V., Lothe, I. M. B., Labori, K. J., Lingjærde, O. C., Buanes, T. A., Dalsgaard, A. M., Skrede, M., Hamfjord, J., Haaland, T., Eide, T. J., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.002 · Cited by 43
RB1 Deletion in Retinoblastoma Protein Pathway-Disrupted Cells Results in DNA Damage and Cancer Progression
Marshall, A. E., Roes, M. V., Passos, D. T., DeWeerd, M. C., Chaikovsky, A. C., Sage, J., Howlett, C. J., & Dick, F. A. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00105-19 · Cited by 45
pRb, a local chromatin organizer with global possibilities
Longworth, M. S., & Dyson, N. J. (2009) · Chromosoma · doi:10.1007/s00412-009-0238-0 · Cited by 45
E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
Fukuda, K., Abei, M., Ugai, H., Seo, E., Wakayama, M., Murata, T., Todoroki, T., Tanaka, N., Hamada, H., & Yokoyama, K. K. (2003) · PubMed · Cited by 43
Molecular Pathobiology of Uveal Melanoma
Ehlers, J. P., & Harbour, J. W. (2005) · International Ophthalmology Clinics · doi:10.1097/01.iio.0000195855.31324.db · Cited by 43
Angiotensin II induces human astrocyte senescence through reactive oxygen species production
Liu, G., Hosomi, N., Hitomi, H., Pelisch, N., Fu, H., Masugata, H., Murao, K., Ueno, M., Matsumoto, M., & Nishiyama, A. (2011) · Hypertension Research · doi:10.1038/hr.2010.269 · Cited by 42
Conserved RB functions in development and tumor suppression
Gordon, G. M., & Du, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1117-z · Cited by 45
Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice
Gromley, A., Churchman, M. L., Zindy, F., & Sherr, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902310106 · Cited by 46
Self-citation
Current status of mathematical modeling of cancer – From the viewpoint of cancer hallmarks
Magi, S., Iwamoto, K., & Okada, M. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.02.008 · Cited by 43
Apurinic/Apyrimidinic Endonuclease 1 Is a Key Modulator of Keratinocyte Inflammatory Responses
Lee, H., Yuk, J., Shin, D., Yang, C., Kim, K., Choi, D.-K., Liang, Z.-L., Kim, J., Jeon, B. H., Kim, C. D., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901856 · Cited by 42
Negative Clonal Selection in Tumor Evolution
Beckman, R. A., & Loeb, L. A. (2005) · Genetics · doi:10.1534/genetics.105.040840 · Cited by 42
Combined Inhibition of MEK and Mammalian Target of Rapamycin Abolishes Phosphorylation of Cyclin-Dependent Kinase 4 in Glioblastoma Cell Lines and Prevents Their Proliferation
Paternot, S., & Roger, P. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3260 · Cited by 42
An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation
Zhao, R., Yang, F. T., & Alexander, D. R. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00333-7 · Cited by 42
Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma
Rallis, K. S., George, A. M., Wozniak, A. M., Bigogno, C. M., Chow, B., HANRAHAN, J. G., & Sideris, M. C. (2022) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20328 · Cited by 42
The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues
Wang, L., Yu, J., Xu, J., Zheng, C., Li, X., & Du, J. (2014) · Gene · doi:10.1016/j.gene.2014.10.032 · Cited by 41
P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer
Shan, M., Zhang, X., Liu, X., Yu, Q., Liu, T., Liu, Y., Ji, W., Zhong, Z., Zhang, Y., Geng, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076408 · Cited by 41
Microtubule Disruption and Tumor Suppression by Mitogen-Activated Protein Kinase Phosphatase 4
Liu, Y., Lagowski, J. P., Sundholm, A. J., Sundberg, A., & Kulesz-Martin, M. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1968 · Cited by 42
Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency
Cheng, L., Zhou, Z., Flesken‐Nikitin, A., Toshkov, I., Wang, W., Camps, J., Ried, T., & Nikitin, A. Y. (2010) · Oncogene · doi:10.1038/onc.2010.300 · Cited by 46
Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Donovan, P., Cato, K., Legaie, R., Jayalath, R., Olsson, G., Hall, B. I., Olson, S., Boros, S., Reynolds, B. A., & Harding, A. S. (2014) · Molecular BioSystems · doi:10.1039/c3mb70484j · Cited by 40
The microproteome of cancer: From invisibility to relevance
Merino-Valverde, I., Greco, E., & Abad, M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111997 · Cited by 40
The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes
Paternot, S., Bianca, C., Bisteau, X., & Roger, P. P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.946841 · Cited by 41
Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16INK4a expression via DNA methylation
Kim, Y., Jung, J. K., Lee, S. Y., & Jang, K. L. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.07.007 · Cited by 41
Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands
Stewart, C. J. R., Crook, M. L., Leung, Y. C., & Platten, M. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.33 · Cited by 41
Rplp1 bypasses replicative senescence and contributes to transformation
Artero‐Castro, A., Kondoh, H., Fernández-Marcos, P. J., Serrano, M., y Cajal, S. R., & LLeonart, M. E. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.02.007 · Cited by 41
Mechanisms of Disease: genetic predictors of response to treatment in brain tumors
Collins, V. P. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0820 · Cited by 41
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 49
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 46
High OCT4 and Low p16 INK4A Expressions Determine In Vitro Lifespan of Mesenchymal Stem Cells
Piccinato, C. D. A., Sertie, A. L., Torres, N., Ferretti, M., & Antonioli, E. (2015) · Stem Cells International · doi:10.1155/2015/369828 · Cited by 42
Flavopiridol Synergizes with Sorafenib to Induce Cytotoxicity and Potentiate Antitumorigenic Activity in EGFR/HER-2 and Mutant RAS/RAF Breast Cancer Model Systems
Nagaria, T. S., Williams, J. L., Leduc, C., Squire, J. A., Greer, P. A., & Sangrar, W. (2013) · Neoplasia · doi:10.1593/neo.13804 · Cited by 39
Polyomavirus-Associated Trichodysplasia Spinulosa Involves Hyperproliferation, pRB Phosphorylation and Upregulation of p16 and p21
Kazem, S., van der Meijden, E., Wang, R. C., Rosenberg, A. S., Pope, E., Benoit, T., Fleckman, P. H., & Feltkamp, M. C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108947 · Cited by 39
Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma
Cui, Q., Jiang, W., Wang, Y., Lv, C., Luo, J., Zhang, W., Lin, F., Yin, Y., Cai, R., Wei, P., et al. (2007) · Hepatology · doi:10.1002/hep.21951 · Cited by 43
Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb
Egger, J. V., Lane, M. V., Antonucci, L., Dedi, B., & Krucher, N. A. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1235668 · Cited by 39
Epigenetic Regulation of Noncoding Rna Transcription by Mammalian Rna Polymerase III
Park, J., Lee, Y.-S., Kunkeaw, N., Kim, S., Kim, I.-H., & Lee, Y. S. (2017) · Epigenomics · doi:10.2217/epi-2016-0108 · Cited by 40
Focal Rosai–Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation
Garces, S. A., Yin, C. C., Patel, K. P., Khoury, J. D., Manning, J. T., Li, S., Xu, J., Piña‐Oviedo, S., Johnson, M. R., González, S., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0152-1 · Cited by 40
Molecular and clinicopathologic characterization of intravenous leiomyomatosis
Ordulu, Z., Chai, H., Peng, G., McDonald, A. G., Nictolis, M. D., García‐Fernández, E., Hardisson, D., Prat, J., Li, P., Hui, P., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0546-8 · Cited by 40
Role of telomeres in vascular senescence
Minamino, T. (2007) · Frontiers in bioscience · doi:10.2741/2902 · Cited by 39
Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS
Agger, K., Santoni‐Rugiu, E., Holmberg, C., Karlström, O. H., & Helin, K. (2004) · Oncogene · doi:10.1038/sj.onc.1208248 · Cited by 43
Interplay between the retinoblastoma protein and LEK1 specifies stem cells toward the cardiac lineage
Papadimou, E., Ménard, C., Grey, C., & Pucéat, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600652 · Cited by 40
Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression
Dib, A., Peterson, T. R., Raducha-Grace, L., Zingone, A., Zhan, F., Hanamura, I., Barlogie, B., Shaughnessy, J. D., & Kuehl, W. M. (2006) · Cell Division · doi:10.1186/1747-1028-1-23 · Cited by 40
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling
Engström, W., Darbre, P. D., Eriksson, S., Gulliver, L., Hultman, T., Karamouzis, M. V., Klaunig, J. E., Mehta, R., Moorwood, K., Sanderson, J. T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv030 · Cited by 40
The retinoblastoma protein: a master tumor suppressor acts as a link between cell cycle and cell adhesion
Cress, W. D., Engel, B. E., & Santiago‐Cardona, P. G. (2014) · Cell Health and Cytoskeleton · doi:10.2147/chc.s28079 · Cited by 45
Cyclin T1 overexpression induces malignant transformation and tumor growth
Moiola, C. P., Luca, P. D., Gardner, K. L., Vazquez, E. S., & Siervi, A. D. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12526 · Cited by 39
Human papillomavirus and lung cancinogenesis: an overview
de Freitas, A. C., Gurgel, A. P. A. D., de Lima, É. G., Marcos, B. D. F. S., & do Amaral, C. M. M. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2197-1 · Cited by 39
Pathways from senescence to melanoma: focus on MITF sumoylation
Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Oncogene · doi:10.1038/onc.2017.292 · Cited by 43
MicroRNA-377: A therapeutic and diagnostic tumor marker
Akhlaghipour, I., Taghehchian, N., Zangouei, A. S., Maharati, A., Mahmoudian, R. A., Saburi, E., & Moghbeli, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.236 · Cited by 40
G1 and S-Phase Checkpoints, Chromosome Instability, and Cancer
Nojima, H. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:003 · Cited by 39
Constitutive Phosphorylation Mutation in Fas-associated Death Domain (FADD) Results in Early Cell Cycle Defects
Osborn, S. L., Sohn, S. J., & Winoto, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703163200 · Cited by 39
Retinoblastoma Deficiency Increases Chemosensitivity in Lung Cancer
Zagórski, W., Knudsen, E. S., & Reed, M. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4753 · Cited by 40
Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells
Zhou, L., Wu, H., Lee, P., & Wang, Z. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02062 · Cited by 39
Immunohistochemical α- and β-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma
Nozawa, N., Hashimoto, S., Nakashima, Y., Matsuo, Y., Koga, T., Sugio, K., Niho, Y., Harada, M., & Sueishi, K. (2006) · Pathology - Research and Practice · doi:10.1016/j.prp.2006.03.007 · Cited by 39
Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In Vitro and In Vivo
Young, A.-M., Archibald, K. M., Tookman, L. A., Pool, A., Dudek, K., Jones, C., Williams, S. L., Pirlo, K. J., Willis, A. E., Lockley, M., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.116 · Cited by 39
DPL-1 DP, LIN-35 Rb and EFL-1 E2F Act With the MCD-1 Zinc-Finger Protein to Promote Programmed Cell Death inCaenorhabditis elegans
Reddien, P. W., Andersen, E. C., Huang, M. C., & Horvitz, H. R. (2007) · Genetics · doi:10.1534/genetics.106.068148 · Cited by 39
miR‐203 Is a Direct Transcriptional Target of E2F1 and Causes G1 Arrest in Esophageal Cancer Cells
Zhang, K., Dai, L., Zhang, B., Xu, X., Shi, J., Fu, L., Chen, X., Li, J., & Bai, Y. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24821 · Cited by 37
MDM2 and MDMX in Cancer and Development
Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 39
Policing and punishment across the domains of social evolution
Singh, M., & Boomsma, J. (2015) · Oikos · doi:10.1111/oik.02064 · Cited by 38
Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells
Urrego, D., Movsisyan, N., Ufartes, R., & Pardo, L. A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1138187 · Cited by 38
Phenolics extracted from tartary (Fagopyrum tartaricum L. Gaerth) buckwheat bran exhibit antioxidant activity, and an antiproliferative effect on human breast cancer MDA-MB-231 cells through the p38/MAP kinase pathway
Li, F., Zhang, X., Li, Y., Lu, K., Yin, R., & Ming, J. (2016) · Food & Function · doi:10.1039/c6fo01230b · Cited by 40
Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
Atat, O. E., Naser, R., Abdelkhalek, M., Abi‐Habib, R. J., & El‐Sibai, M. (2022) · Oncology Letters · doi:10.3892/ol.2022.13632 · Cited by 40
The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer
Gu, Z., Zhang, F., Wang, Z.-Q., Ma, W., Davis, R. E., & Wang, Z. (2012) · Oncogene · doi:10.1038/onc.2012.207 · Cited by 38
Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System
Nieto‐Sampedro, M., Valle‐Argos, B., Gómez‐Nicola, D., Fernández‐Mayoralas, A., & Nieto‐Díaz, M. (2011) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s7685 · Cited by 39
Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia
Matoso, A., Zhou, Z., Hayama, R., Flesken‐Nikitin, A., & Nikitin, A. Y. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm207 · Cited by 38
Gene Expression Profiling Data in Lymphoma and Leukemia: Review of the Literature and Extrapolation of Pertinent Clinical Applications
Dunphy, C. H. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-483-gepdil · Cited by 38
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen
Lehn, S., Fernö, M., Jirström, K., Rydén, L., & Landberg, G. (2011) · Cell Cycle · doi:10.4161/cc.10.6.15074 · Cited by 37
PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma
Passaro, C., Volpe, M., Botta, G., Scamardella, E., Perruolo, G., Gillespie, D. A., Libertini, S., & Portella, G. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.022 · Cited by 37
Senescence‐Associated Molecular and Epigenetic Alterations in Mesenchymal Stem Cell Cultures from Amniotic Fluid of Normal and Fetus‐Affected Pregnancy
Savickienė, J., Baronaitė, S., Zentelytė, A., Treigytė, G., & Navakauskienė, R. (2016) · Stem Cells International · doi:10.1155/2016/2019498 · Cited by 39
Transcriptional deregulation underlying the pathogenesis of small cell lung cancer
Kim, D. W., Kim, K., Kim, K., Dunn, C. T., & Park, K.-S. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.10.07 · Cited by 36
p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus
Paulson, T. G., Galipeau, P. C., Xu, L., Kissel, H. D., Li, X., Blount, P. L., Sanchez, C. A., Odze, R. D., & Reid, B. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003809 · Cited by 37

Authors: Sherr, C. J., & McCormick, F.
Affiliations: St. Jude Children's Research Hospital (US)
University of California, San Francisco (US)
Corresponding author: Sherr, Charles J
ORCID: Sherr, Charles J
McCormick, Frank
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2002-08
Volume: 2
Issue: 2
Pages: 103-112
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/s1535-6108(02)00102-2
OpenAlex: W1992708996
Cited by: 1,690
References: 122
Citations by year: 2026: 31 · 2025: 40 · 2024: 36 · 2023: 60 · 2022: 56 · 2021: 62 · 2020: 62 · 2019: 67 · 2018: 75 · 2017: 67 · 2016: 60 · 2015: 71 · 2014: 88 · 2013: 81 · 2012: 90
FWCI: 7.67
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4003 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: retinoblastoma protein, p53, tumor suppressor, malignant transformation, signaling pathways, cancer etiology, tumor-specific therapy, oncogenic transformation
MeSH terms: Cell Cycle, DNA-Binding Proteins, Humans, Neoplasms, Transcription Factors, Signal Transduction, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, E2F Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The RB and p53 pathways in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks